SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-005918
Filing Date
2021-05-05
Accepted
2021-05-05 16:10:46
Documents
74
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ampe-20210331x10q.htm   iXBRL 10-Q 1266295
2 EX-31.1 ampe-20210331xex31d1.htm EX-31.1 15554
3 EX-31.2 ampe-20210331xex31d2.htm EX-31.2 15541
4 EX-32.1 ampe-20210331xex32d1.htm EX-32.1 8065
5 GRAPHIC ampe-20210331x10q002.jpg GRAPHIC 2119
6 GRAPHIC ampe-20210331x10q003.jpg GRAPHIC 35097
7 GRAPHIC ampe-20210331x10q004.jpg GRAPHIC 34709
  Complete submission text file 0001558370-21-005918.txt   6346331

Data Files

Seq Description Document Type Size
8 EX-101.SCH ampe-20210331.xsd EX-101.SCH 51045
9 EX-101.CAL ampe-20210331_cal.xml EX-101.CAL 40099
10 EX-101.DEF ampe-20210331_def.xml EX-101.DEF 157624
11 EX-101.LAB ampe-20210331_lab.xml EX-101.LAB 362570
12 EX-101.PRE ampe-20210331_pre.xml EX-101.PRE 312222
13 EXTRACTED XBRL INSTANCE DOCUMENT ampe-20210331x10q_htm.xml XML 1223302
Mailing Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112
Business Address 373 INVERNESS PARKWAY SUITE 200 ENGLEWOOD CO 80112 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35182 | Film No.: 21893339
SIC: 2834 Pharmaceutical Preparations